Alvesco 40, 80 and 160 Inhaler
Last Updated on eMC 05-Jun-2017 View document | AstraZeneca UK Limited Contact details
Versions
- 05-Jun-2017 to Current
- 07-Jan-2016 to 05-Jun-2017
- 24-Apr-2015 to 07-Jan-2016
- 16-Jul-2014 to 24-Apr-2015
- 18-Dec-2012 to 16-Jul-2014
- 08-Jun-2011 to 18-Dec-2012
- 25-Oct-2010 to 08-Jun-2011
- 31-Aug-2010 to 25-Oct-2010
- 17-Feb-2010 to 31-Aug-2010
- 17-Apr-2009 to 17-Feb-2010
- 19-Feb-2009 to 17-Apr-2009
- 15-Jan-2009 to 19-Feb-2009
- 25-Feb-2008 to 15-Jan-2009
- 13-Jul-2007 to 25-Feb-2008
- 10-Jul-2006 to 13-Jul-2007
- 05-May-2005 to 10-Jul-2006
- 28-Apr-2005 to 05-May-2005
- 15-Feb-2005 to 28-Apr-2005
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 05-Jun-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 6 - marketing authorisation holder
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 07-Jan-2016 and displayed until 05-Jun-2017
Reasons for adding or updating:
- Change to section 5 - how to store
Updated on 24-Apr-2015 and displayed until 07-Jan-2016
Reasons for adding or updating:
- Change to section 6 - date of revision
Updated on 16-Jul-2014 and displayed until 24-Apr-2015
Reasons for adding or updating:
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
Updated on 18-Dec-2012 and displayed until 16-Jul-2014
Reasons for adding or updating:
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 08-Jun-2011 and displayed until 18-Dec-2012
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
Updated on 25-Oct-2010 and displayed until 08-Jun-2011
Reasons for adding or updating:
- Improved Electronic Presentation
Updated on 31-Aug-2010 and displayed until 25-Oct-2010
Reasons for adding or updating:
- Improved Electronic Presentation
Updated on 17-Feb-2010 and displayed until 31-Aug-2010
Reasons for adding or updating:
- Change due to harmonisation of PIL.
- Change to Further Information section
- Change to date of revision
- Change to side-effects
- Change to manufacturer contact details
Updated on 17-Apr-2009 and displayed until 17-Feb-2010
Reasons for adding or updating:
- Change to date of revision
- Change to side-effects
Updated on 19-Feb-2009 and displayed until 17-Apr-2009
Reasons for adding or updating:
- Change to date of revision
- Change of manufacturer
Updated on 15-Jan-2009 and displayed until 19-Feb-2009
Reasons for adding or updating:
- Transfer to upgraded management system
Updated on 25-Feb-2008 and displayed until 15-Jan-2009
Reasons for adding or updating:
- Change of licence holder
- Company name change or merger
- Change to MA holder contact details
- Change to date of revision
Updated on 13-Jul-2007 and displayed until 25-Feb-2008
Reasons for adding or updating:
- Improved Electronic Presentation
Updated on 10-Jul-2006 and displayed until 13-Jul-2007
Reasons for adding or updating:
- Change to, or new, use for medicine
- Change to side-effects
Updated on 05-May-2005 and displayed until 10-Jul-2006
Reasons for adding or updating:
- Change to packaging
- Change of contra-indications
- Change to side-effects
- Change to information about pregnancy or lactation
- Change to information about driving or using machinery
- Change to date of revision
Updated on 28-Apr-2005 and displayed until 05-May-2005
Reasons for adding or updating:
- Change to side-effects
- Change to drug interactions
- Change to information about pregnancy or lactation
- Change to information about driving or using machinery
- Change to date of revision
- Change to storage instructions
- Change to packaging
Updated on 15-Feb-2005 and displayed until 28-Apr-2005
Reasons for adding or updating:
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
+44 (0)1582 838 000
+44 (0)1582 838 003
+44 (0)1582 836 000
0800 783 0033
+44 (0)1582 837 837
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue